Racial differences in the impact of pre-existing mental health diagnosis on colorectal cancer survival: A single-center retrospective propensity-matched analysis.

H Hasiya Yusuf (Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA) E Elham Babadi (Emory University School of Medicine, Atlanta, GA) T Tarrant McPherson (2Emory University, Winship Cancer Institute, Atlanta, United States) T Tyler Whitfield (Emory Winship Cancer Institute, Atlanta, GA) L Lindsay Marie Hannan (Winship Cancer Institute of Emory University, Atlanta, GA) F Frank Eady (Emory University, Atlanta, GA) Y Yuan Liu W Wendy Baer (Emory Clinic, Atlanta, GA) O Olatunji B. Alese (Winship Cancer Institute of Emory University, Atlanta, GA)

Abstract

45 Background: Racial disparities in colorectal cancer (CRC) epidemiology and mortality have been well documented, with Black patients having higher rates of late-stage presentations and worse survival outcomes. However, the differential impact of a pre-existing mental health diagnosis (MHD) on CRC outcomes across racial groups has not been well-studied. Methods: We conducted a retrospective study of patients with CRC treated at a major cancer center between 2015 and 2020. Patients with a documented MHD prior to their CRC diagnosis were included in the analysis. The cohort was further refined using 1:1 propensity score matching (PSM), performed to balance demographic and clinical confounders, including age, tumor site, cancer stage, insurance status, and tobacco use across Black and non-Black patients. Survival outcomes were assessed using Cox proportional hazards models, stratified by cancer stage and including an interaction term between race and pre-existing MHD. Statistical significance was set at 0.05. Results: Of 2,713 patients with CRC and non-missing race data (Black: 1,028; White/Other: 1,685), 2,056 were included in the analysis after PSM. Median age - 62 years, 52% were female, 80% had colon cancer, and 12% reported tobacco use. Stage distribution - I (21%), II (16.5%), III (27.3%), and IV (35%). Pre-existing MHD was present in 26/1028 (2.5%) of Black and 23/1028 (2.3%) of non-Black patients. Baseline characteristics were balanced between racial groups, though patients with pre-existing MHD were more often female or older (Table 1). Sex and age at diagnosis were included in proportional hazards models. Black race and pre-existing MHD were independently associated with shorter survival; mOS 55 mos for Black vs. 89 mos for non-Black patients (HR 1.50, 95% CI 1.3–1.7, p <0.01). Interaction analysis showed that Black patients with pre-existing MHD had worse survival outcomes compared with non-Black patients; mOS 30 mos vs. 51 mos (HR 3.2, 95% CI 1.6 - 6.7, p=0.035). Conclusions: Black patients with CRC and pre-existing MHD experienced significantly worse survival. There is an urgent need for integrated oncology with mental health services, particularly among racial minorities. Future prospective studies to mitigate these survival gaps are needed.

Article Details

Volume / Issue Vol. 44, Issue 2_suppl
Published January 10, 2026
Pages 45-45
ISSN 0732-183X
Publisher Lippincott Williams & Wilkins

Journal Info

Journal of Clinical Oncology

Lippincott Williams & Wilkins

ISSN: 0732-183X Health Sciences

Authors (9)

H

Hasiya Yusuf

Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA

E

Elham Babadi

Emory University School of Medicine, Atlanta, GA

T

Tarrant McPherson

2Emory University, Winship Cancer Institute, Atlanta, United States

T

Tyler Whitfield

Emory Winship Cancer Institute, Atlanta, GA

L

Lindsay Marie Hannan

Winship Cancer Institute of Emory University, Atlanta, GA

F

Frank Eady

Emory University, Atlanta, GA

Y

Yuan Liu

W

Wendy Baer

Emory Clinic, Atlanta, GA

O

Olatunji B. Alese

Winship Cancer Institute of Emory University, Atlanta, GA